SCHEMBL29329753

SCHEMBL29329753

Clc1c2c(nc3c(Br)cnn13)C1(CCCCC1)CC2

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29329745 0.99 GSK3B (0.30) GSK3B
SCHEMBL29329756 0.93 GSK3B (0.32) GSK3B
SCHEMBL29329751 0.86
SCHEMBL29329743 0.85
SCHEMBL29330415 0.83 HPGD (0.31)
SCHEMBL29329747 0.83
SCHEMBL29329762 0.82
SCHEMBL29329628 0.81 CHEK1 (0.33)
SCHEMBL30991893 0.81 CYP1A2 (0.33) GSK3B
SCHEMBL29329842 0.80 HRH3 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024151112-A1 PYRAZOLOPYRIMIDINE DERIVATIVE AS CYCLIN-DEPENDENT KINASE 9 INHIBITOR 주식회사 티움바이오 2024-07-18 WO disclosed